Myseum.AI heads into its Q1 2026 earnings print — expected May 20 — with short positioning reset sharply higher after weeks of wild lending-market volatility.
The standout story this week is the extreme cost-to-borrow reading. Borrowing MYSE shares currently costs around 187% annually — a number that would be extraordinary for most stocks. But it is actually a dramatic improvement from where it was in late April, when CTB peaked above 560%. That spike followed a sustained compression in share availability through mid-April, when the borrow market hit its tightest point of the past year. Since then, costs have eased roughly 18% over the past week, though at 187% they remain deeply elevated. Availability has opened back up to around 229% of short interest, meaning there is more than twice as much stock available to lend as there are existing short positions — lending conditions have loosened significantly since the April squeeze, but the rate is still punishing for anyone holding a short position.
Short interest tells an equally turbulent story. SI as a percentage of the free float was below 0.5% at the start of May. By May 12, it had climbed to nearly 6.7%. The latest reading is 5.2% of float — up more than 750% week-on-week in raw share terms. That kind of move in a stock with a sub-$8 million market cap points to speculative positioning around the approaching earnings date, not a structural bear thesis. The ORTEX short score is running at 64, up sharply from 52 at the start of the month, and days-to-cover ranks in the 92nd percentile — both signals that the lending market is treating this as an elevated-risk situation right now.
Context from the prior earnings cycle matters here. In April, when MYSE reported full-year 2025 results, the stock moved more than 124% on the day — an outlier driven by micro-cap mechanics rather than fundamental valuation. Q1 figures just filed show EPS of -$0.67, widening from -$0.34 a year earlier, on revenue that declined to $73,000 from $92,000. Those numbers highlight just how early-stage this company is: annual revenue is measured in tens of thousands of dollars, not millions. At the current price of $1.81, the stock is up 23% over the past month despite the deteriorating financials. The rebranding to Myseum.AI earlier in April and a presentation slot at the LD Micro Invitational Conference this week are the narrative drivers keeping interest alive.
Institutional ownership is thinly distributed and largely passive. Vanguard holds around 1.1% and Geode around 0.8%, both essentially index-driven. Citadel opened a new position in the stock as of December 31. No institutional holder controls a meaningful block, and with total tracked holders at 15, this is not a stock with deep institutional sponsorship. Insider activity on record runs to September 2025, when founder and CEO Darin Myman purchased small batches of shares at prices around $2.00–$2.17. Those purchases were modest in absolute dollar terms — combined value around $37,000 — but consistent across multiple sessions, suggesting measured accumulation rather than a single statement trade.
The setup heading into May 20 is straightforward to describe. Short interest has rebuilt quickly from near-zero to above 5% of float. The borrow rate, though easing, remains exceptionally high. The April earnings print produced a triple-digit one-day move. Revenue is shrinking and losses are widening. All of this means the print is less a test of business progress and more a test of whether the AI-rebranding narrative can sustain attention in a micro-cap stock where sentiment and positioning dynamics dominate the price action.
See the live data behind this article on ORTEX.
Open MYSE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
